Jingyu Li Selected Research

HMGN2 Protein (HMGN2)

12/2019	HMGN2 regulates non-tuberculous mycobacteria survival via modulation of M1 macrophage polarization.
1/2019	High-mobility group protein N2 induces autophagy by activating AMPK/ULK1 pathway and thereby boosts UPEC proliferation within bladder epithelial cells.
1/2017	Nuclear protein HMGN2 attenuates pyocyanin-induced oxidative stress via Nrf2 signaling and inhibits Pseudomonas aeruginosa internalization in A549 cells.
9/2016	Knockdown of HMGN2 increases the internalization of Klebsiella pneumoniae by respiratory epithelial cells through the regulation of α5β1 integrin expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jingyu Li Research Topics

Disease

14	Neoplasms (Cancer) 08/2022 - 04/2016
8	Infections 11/2020 - 10/2014
4	Inflammation (Inflammations) 01/2020 - 12/2014
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 07/2014
3	Breast Neoplasms (Breast Cancer) 01/2021 - 03/2012
2	Hypoxia (Hypoxemia) 06/2022 - 11/2013
2	Carcinoma (Carcinomatosis) 04/2022 - 01/2020
2	Body Weight (Weight, Body) 04/2022 - 03/2021
2	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2021 - 01/2021
2	Chronic Renal Insufficiency 11/2020 - 04/2018
2	Congenital Abnormalities (Deformity) 10/2020 - 01/2020
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2019 - 01/2019
2	Tuberculosis (Tuberculoses) 12/2019 - 11/2018
2	Neoplasm Metastasis (Metastasis) 01/2018 - 01/2018
1	Nasopharyngeal Carcinoma 08/2022
1	Hemorrhage 08/2022
1	Melanoma (Melanoma, Malignant) 08/2022
1	Microsatellite Instability 06/2022
1	Endometrial Neoplasms (Endometrial Cancer) 06/2022
1	Renal Insufficiency (Renal Failure) 04/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 04/2022
1	Acidosis 04/2022
1	Obesity 01/2022
1	COVID-19 01/2022
1	Hypothermia 01/2022
1	Hyperplasia 01/2022
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 11/2021
1	Osteoarthritis 04/2021
1	Anorexia 03/2021
1	Cachexia 03/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Poliomyelitis (Polio) 01/2021
1	Femoral Neck Fractures 01/2021
1	Disease Progression 01/2021
1	Single Umbilical Artery 10/2020
1	Rectal Neoplasms (Rectal Cancer) 02/2020
1	Insulin Resistance 01/2020
1	Squamous Cell Carcinoma of Head and Neck 01/2020
1	Osteosarcoma (Osteogenic Sarcoma) 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Hyperthermia 01/2020

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 04/2022 - 11/2013
4	Long Noncoding RNAIBA 06/2022 - 11/2020
4	HMGN2 Protein (HMGN2)IBA 12/2019 - 09/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 02/2020
2	Phospholipid Transfer ProteinsIBA 02/2020 - 01/2018
2	PyocyanineIBA 01/2020 - 01/2017
2	Pregnenolone Carbonitrile (PCN)IBA 01/2020 - 01/2017
2	Virulence Factors (Pathogenicity Factors)IBA 01/2020 - 01/2017
2	Nuclear Proteins (Protein, Nuclear)IBA 01/2019 - 01/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2018 - 01/2017
2	LuteolinIBA 11/2016 - 10/2014
1	2-MethoxyestradiolIBA 08/2022
1	Estrogens (Estrogen)FDA Link 08/2022
1	Mercaptoethanol (2 Mercaptoethanol)IBA 08/2022
1	anagliptinIBA 04/2022
1	Dialysis SolutionsIBA 04/2022
1	CyclodextrinsIBA 04/2022
1	indoxylIBA 04/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 04/2022
1	Small-Conductance Calcium-Activated Potassium Channels (SK Potassium Channels)IBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	Sirtuin 3IBA 11/2021
1	Peptide Hormones (Polypeptide Hormones)IBA 03/2021
1	AdipokinesIBA 03/2021
1	silicon carbideIBA 01/2021
1	TantalumIBA 01/2021
1	SphingomyelinsIBA 01/2021
1	Biological ProductsIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Mitogen-Activated Protein KinasesIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Glycerophospholipids (Phosphoglycerides)IBA 01/2021
1	LipidsIBA 01/2021
1	NucleotidesIBA 01/2021
1	VaccinesIBA 01/2021
1	Uremic ToxinsIBA 11/2020
1	sodium salt monooctadecyl ester fumaric acidIBA 10/2020
1	Small Interfering RNA (siRNA)IBA 01/2020
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 01/2020
1	phenazine FDA Link 01/2020
1	740Y-PIBA 01/2020
1	histone H3 trimethyl Lys4IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	graphene oxideIBA 01/2020
1	Peroxynitrous Acid (Peroxynitrite)IBA 01/2020
1	Alcian BlueIBA 01/2020
1	Insulin (Novolin)FDA Link 01/2020

Therapy/Procedure

9	Therapeutics 08/2022 - 11/2013
3	Immunotherapy 08/2022 - 08/2014
2	Radiotherapy 08/2022 - 08/2014
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2018 - 07/2014
2	Drug Therapy (Chemotherapy) 08/2014 - 03/2012
1	Re-Irradiation 08/2022
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2022
1	Operative Surgical Procedures 01/2022
1	Bone Screws 01/2021
1	Renal Dialysis (Hemodialysis) 11/2020
1	Neoadjuvant Therapy 02/2020
1	Photothermal Therapy 01/2020